| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |